Sumesh Kachroo, PhD

Janssen Scientific Affairs, LLC

Poster(s):

• P0788 - Real-World Treatment Persistence Among Bio-Naïve Patients With Ulcerative Colitis Initiated on Ustekinumab or Adalimumab
  Sunday, October 22, 2023

  3:30 PM – 7:00 PM PT

• P0789 - Persistence Among Patients with Ulcerative Colitis Previously Treated with an Anti-Tumor Necrosis Factor Inhibitor and Switching or Cycling to Another Biologic Agent
  Sunday, October 22, 2023

  3:30 PM – 7:00 PM PT

• P0790 - Real-World Prevalence of Potential Drug-Drug Interactions Associated With Oral Advanced Therapies Indicated for Ulcerative Colitis
  Sunday, October 22, 2023

  3:30 PM – 7:00 PM PT